Sigilon Therapeutics, Inc. Contracts & Agreements

57 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consulting Agreement, dated October 13, 2021, between the Company and May Orfali, M.D
Consulting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2022
Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan, as amended on May 23, 2023
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
2023
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan, as amended on May 23, 2023
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
2023
Sigilon Therapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended on May 23, 2023
Stock Agreements
Sigilon Therapeutics, Inc.
2023
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy, as amended on May 23, 2023
Compensation Agreements
Sigilon Therapeutics, Inc.
2023
Agreement and Plan of Merger, dated as of June 28, 2023, among Eli Lilly and Company, Shenandoah Acquisition Corporation and Sigilon Therapeutics, Inc
Merger Agreements
Sigilon Therapeutics, Inc.
2023
Form of Contingent Value Right Agreement, by and among Eli Lilly and Company and a rights agent selected by Eli Lilly and Company and reasonably acceptable to Sigilon...
Sigilon Therapeutics, Inc.
2023
Consulting Agreement, dated February 14, 2023, between the Company and May Orfali, M.D
Consulting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2023
Letter Agreement, dated February 10, 2023, between the Company and May Orfali, M.D
Sigilon Therapeutics, Inc.
2023
Offer Letter, between Sigilon Therapeutics, Inc. and Sarah Yuan, dated January 12, 2022
Sigilon Therapeutics, Inc.
2023
Offer Letter, between Sigilon Therapeutics, Inc. and Josias Pontes, dated October 23, 2019
Sigilon Therapeutics, Inc.
Biotechnology
2023
Form of Restricted Stock Unit Agreement under the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
2023
First Amendment to Research Collaboration and Exclusive License Agreement by and among Sigilon Therapeutics, Inc. and Eli Lilly and Company, dated May 5, 2022
Collaboration Agreements
Sigilon Therapeutics, Inc.
Biotechnology
NY
2022
Sixth Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated February 1, 2022
License Agreements
Sigilon Therapeutics, Inc.
2022
Offer Letter, between Sigilon Therapeutics, Inc. and May Orfali, M.D. dated October 27, 2021
Sigilon Therapeutics, Inc.
2022
Offer Letter, between Sigilon Therapeutics, Inc. and Philip Ashton-Rickardt, dated May 25, 2021
Sigilon Therapeutics, Inc.
Biotechnology
MA
2022
Offer Letter, between Sigilon Therapeutics, Inc. and Deya Corzo, M.D. dated September 26, 2018
Sigilon Therapeutics, Inc.
2022
Letter Agreement, dated August 4, 2021, between the Company and Deya Corzo, M.D
Sigilon Therapeutics, Inc.
2022
Fifth Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated September 17, 2021
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Consulting Agreement between Sigilon Therapeutics, Inc. and Devyn Smith, dated April 26, 2021
Consulting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2021
Description of Registered Securities
Sigilon Therapeutics, Inc.
Biotechnology
2021
Second Amendment to Lease, by and among ARE-MA Region No. 45, LLC and Sigilon Therapeutics, Inc., dated January 19, 2021
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Fourth Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated December 10, 2020
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2021
Form of Underwriting Agreement
Underwriting Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Form of Non-Statutory Stock Option Agreement (Non-Employee Directors)
Stock Agreements
Sigilon Therapeutics, Inc.
2020
Form of Non-Statutory Stock Option Agreement (Employees)
Stock Agreements
Sigilon Therapeutics, Inc.
2020
Form of Incentive Stock Option Agreement
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
2020
Sigilon Therapeutics, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Specimen stock certificate evidencing shares of common stock
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Third Amended and Restated Investors' Rights Agreement, by and among Sigilon Therapeutics, Inc. and the investors party thereto, dated as of October 23, 2020
Investor Rights Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Warrant to Purchase Stock, between Sigilon Therapeutics, Inc. and Pacific Western Bank, dated January 24, 2018
Warrant Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Warrant to Purchase Stock, between Sigilon Therapeutics, Inc. and Pacific Western Bank, dated November 7, 2019
Warrant Agreements
Sigilon Therapeutics, Inc.
2020
Form of Warrant to Purchase Stock, between Sigilon Therapeutics, Inc. and Oxford Finance LLC, dated September 2, 2020
Warrant Agreements
Sigilon Therapeutics, Inc.
2020
Lease, by and between ARE-MA Region No. 45, LLC and Sigilon Therapeutics, Inc., dated August 28, 2017
Lease Agreements
Sigilon Therapeutics, Inc.
2020
Lease Agreement, by and between ARE-MA Region No. 45, LLC and Foghorn Therapeutics Inc., dated August 24, 2017
Lease Agreements
Sigilon Therapeutics, Inc.
2020
Assignment and Assumption of Lease, by and between Foghorn Therapeutics Inc. and Sigilon Therapeutics, Inc., dated October 21, 2019
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Consent to Assignment and First Amendment to Lease, by and among ARE-MA Region No. 45, LLC, Foghorn Therapeutics Inc. and Sigilon Therapeutics, Inc., dated October 21, 2019
Lease Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Loan and Security Agreement, by and among Oxford Finance LLC, the Lenders party thereto, and Sigilon Therapeutics, Inc., dated September 2, 2020
Loan Agreements
Sigilon Therapeutics, Inc.
2020
Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated February 8, 2016
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
First Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated February 2, 2017
License Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Second Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated August 9, 2018
License Agreements
Sigilon Therapeutics, Inc.
2020
Third Amendment to Exclusive Patent License Agreement, by and between Massachusetts Institute of Technology and Sigilon Therapeutics, Inc., dated November 6, 2019
License Agreements
Sigilon Therapeutics, Inc.
2020
Research Collaboration and Exclusive License Agreement, by and between Sigilon Therapeutics, Inc. and Eli Lilly and Company, dated April 2, 2018
Collaboration Agreements
Sigilon Therapeutics, Inc.
Biotechnology
IN
2020
Sigilon Therapeutics, Inc. 2016 Stock Option and Grant Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
Biotechnology
DE
2020
Form of Incentive Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
2020
Form of Nonstatutory Stock Option Agreement under the Sigilon Therapeutics, Inc. 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Offer Letter, between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho, M.D., dated April 23, 2018
Sigilon Therapeutics, Inc.
Biotechnology
2020
Offer Letter, between Sigilon Therapeutics, Inc. and Glenn Reicin, dated May 8, 2019
Sigilon Therapeutics, Inc.
2020
Offer Letter, between Sigilon, Inc. and Devyn Smith, dated March 25, 2017
Sigilon Therapeutics, Inc.
2020
Severance Waiver and Offer Letter Amendment, between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho, M.D., dated October 26, 2020
Severance Agreements
Sigilon Therapeutics, Inc.
2020
Form of Non-Chief Executive Officer Severance Waiver and Offer Letter Amendment
Severance Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Stock Restriction Agreement, between Sigilon Therapeutics, Inc. and Daniel G. Anderson, dated February 10, 2016
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Stock Restriction Agreement, between Sigilon Therapeutics, Inc. and Robert S. Langer, dated February 5, 2016
Stock Agreements
Sigilon Therapeutics, Inc.
Biotechnology
MA
2020
Sigilon Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy
Change of Control Agreements
Sigilon Therapeutics, Inc.
Biotechnology
2020
Sigilon Therapeutics, Inc. 2020 Cash Incentive Plan
Bonus & Incentive Agreements
Sigilon Therapeutics, Inc.
2020
Sigilon Therapeutics, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Sigilon Therapeutics, Inc.
2020